Overview

• Prescriptions for the pill among under‑22s dropped from 43 percent in 2015 to 22 percent in 2024, according to the health insurer’s analysis.
• The shift toward lower‑risk combined‑pill formulations stalled in 2024, with both lower‑risk and higher‑risk products each accounting for 48 percent of prescriptions.
• A 2023 BZgA survey shows condoms have overtaken the pill as the most-used contraceptive among young adults in Germany.
• Doctors and researchers cite concerns over side effects and online sharing of personal experiences, with experts emphasizing that clot risk roughly doubles but remains low in absolute terms.
• Researchers report laboratory and animal progress on non‑hormonal male contraceptives, yet they say practical use remains years away.